ECL Access to Medicines Task Force

1 view

Established in 2016, the ECL Access to Medicines Task Force aims to make safe and effective medicines available to all cancer patients in Europe by insisting on accessibility, availability, affordability and increased transparency related to medicine prices, ultimately leading to sustainability of healthcare systems. The Task Force strongly believes in the power of constructive dialogue. We urge all stakeholders to push for accessibility to high quality treatments, improving both survival and the quality of life of cancer patients. The ECL Task Force connects 29 national and regional cancer societies in 24 European countries, representing over 600 million Europeans.


Association of European Cancer Leagues (ECL)
2 videos

Join the conversation

to comment